Inclusion-Body Myositis Clinical Trials 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.Safety and Tolerability of Phenylbutyrate in Inclusion Body Myositis
Conditions: Inclusion Body Myositis; Sporadic Inclusion Body Myositis Intervention: Drug: Phenylbutyrate Oral Tablet Sponsor: University of Kansas Medical Center Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 9, 2020 Category: Research Source Type: clinical trials
Arimoclomol in Sporadic Inclusion Body Myositis - Open Label Extension Trial
Condition: Inclusion Body Myositis Intervention: Drug: Arimoclomol Sponsor: Orphazyme Enrolling by invitation (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 7, 2019 Category: Research Source Type: clinical trials
